Keywords: isis, boehringer, ingelheim, million, link, pharmaceuticals, announced

Isis And Boehringer Ingelheim In $100 Million R&D Link

Article | 06 March 1995

Print This

Isis Pharmaceuticals and Boehringer Ingelheim have announced their intent to collaborate in the area of cell adhesion. The aggregate value ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in